Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Exosomes Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Non-coding RNAs
1.2.3 Lipids
1.2.4 mRNA
1.2.5 DNA fragments
1.2.6 Proteins /peptides
1.3 Market by Application
1.3.1 Global Exosomes Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Cancer
1.3.3 Infectious diseases
1.3.4 Neurodegenerative diseases
1.3.5 Cardiovascular diseases
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Exosomes Market Perspective (2018-2033)
2.2 Exosomes Growth Trends by Region
2.2.1 Global Exosomes Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Exosomes Historic Market Size by Region (2018-2023)
2.2.3 Exosomes Forecasted Market Size by Region (2024-2033)
2.3 Exosomes Market Dynamics
2.3.1 Exosomes Industry Trends
2.3.2 Exosomes Market Drivers
2.3.3 Exosomes Market Challenges
2.3.4 Exosomes Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Exosomes Players by Revenue
3.1.1 Global Top Exosomes Players by Revenue (2018-2023)
3.1.2 Global Exosomes Revenue Market Share by Players (2018-2023)
3.2 Global Exosomes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Exosomes Revenue
3.4 Global Exosomes Market Concentration Ratio
3.4.1 Global Exosomes Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Exosomes Revenue in 2022
3.5 Exosomes Key Players Head office and Area Served
3.6 Key Players Exosomes Product Solution and Service
3.7 Date of Enter into Exosomes Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Exosomes Breakdown Data by Type
4.1 Global Exosomes Historic Market Size by Type (2018-2023)
4.2 Global Exosomes Forecasted Market Size by Type (2024-2033)
5 Exosomes Breakdown Data by Application
5.1 Global Exosomes Historic Market Size by Application (2018-2023)
5.2 Global Exosomes Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Exosomes Market Size (2018-2033)
6.2 North America Exosomes Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Exosomes Market Size by Country (2018-2023)
6.4 North America Exosomes Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Exosomes Market Size (2018-2033)
7.2 Europe Exosomes Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Exosomes Market Size by Country (2018-2023)
7.4 Europe Exosomes Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Exosomes Market Size (2018-2033)
8.2 Asia-Pacific Exosomes Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Exosomes Market Size by Region (2018-2023)
8.4 Asia-Pacific Exosomes Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Exosomes Market Size (2018-2033)
9.2 Latin America Exosomes Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Exosomes Market Size by Country (2018-2023)
9.4 Latin America Exosomes Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Exosomes Market Size (2018-2033)
10.2 Middle East & Africa Exosomes Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Exosomes Market Size by Country (2018-2023)
10.4 Middle East & Africa Exosomes Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Fujifilm
11.1.1 Fujifilm Company Detail
11.1.2 Fujifilm Business Overview
11.1.3 Fujifilm Exosomes Introduction
11.1.4 Fujifilm Revenue in Exosomes Business (2018-2023)
11.1.5 Fujifilm Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Exosomes Introduction
11.2.4 Thermo Fisher Scientific Revenue in Exosomes Business (2018-2023)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Danaher
11.3.1 Danaher Company Detail
11.3.2 Danaher Business Overview
11.3.3 Danaher Exosomes Introduction
11.3.4 Danaher Revenue in Exosomes Business (2018-2023)
11.3.5 Danaher Recent Development
11.4 Illumina
11.4.1 Illumina Company Detail
11.4.2 Illumina Business Overview
11.4.3 Illumina Exosomes Introduction
11.4.4 Illumina Revenue in Exosomes Business (2018-2023)
11.4.5 Illumina Recent Development
11.5 Qiagen
11.5.1 Qiagen Company Detail
11.5.2 Qiagen Business Overview
11.5.3 Qiagen Exosomes Introduction
11.5.4 Qiagen Revenue in Exosomes Business (2018-2023)
11.5.5 Qiagen Recent Development
11.6 Takara Bio
11.6.1 Takara Bio Company Detail
11.6.2 Takara Bio Business Overview
11.6.3 Takara Bio Exosomes Introduction
11.6.4 Takara Bio Revenue in Exosomes Business (2018-2023)
11.6.5 Takara Bio Recent Development
11.7 Malvern Instruments
11.7.1 Malvern Instruments Company Detail
11.7.2 Malvern Instruments Business Overview
11.7.3 Malvern Instruments Exosomes Introduction
11.7.4 Malvern Instruments Revenue in Exosomes Business (2018-2023)
11.7.5 Malvern Instruments Recent Development
11.8 Miltenyi Biotec
11.8.1 Miltenyi Biotec Company Detail
11.8.2 Miltenyi Biotec Business Overview
11.8.3 Miltenyi Biotec Exosomes Introduction
11.8.4 Miltenyi Biotec Revenue in Exosomes Business (2018-2023)
11.8.5 Miltenyi Biotec Recent Development
11.9 MBL International
11.9.1 MBL International Company Detail
11.9.2 MBL International Business Overview
11.9.3 MBL International Exosomes Introduction
11.9.4 MBL International Revenue in Exosomes Business (2018-2023)
11.9.5 MBL International Recent Development
11.10 Lonza
11.10.1 Lonza Company Detail
11.10.2 Lonza Business Overview
11.10.3 Lonza Exosomes Introduction
11.10.4 Lonza Revenue in Exosomes Business (2018-2023)
11.10.5 Lonza Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Exosomes Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Non-coding RNAs
Table 3. Key Players of Lipids
Table 4. Key Players of mRNA
Table 5. Key Players of DNA fragments
Table 6. Key Players of Proteins /peptides
Table 7. Global Exosomes Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Exosomes Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Exosomes Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Exosomes Market Share by Region (2018-2023)
Table 11. Global Exosomes Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Exosomes Market Share by Region (2024-2033)
Table 13. Exosomes Market Trends
Table 14. Exosomes Market Drivers
Table 15. Exosomes Market Challenges
Table 16. Exosomes Market Restraints
Table 17. Global Exosomes Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Exosomes Market Share by Players (2018-2023)
Table 19. Global Top Exosomes Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exosomes as of 2022)
Table 20. Ranking of Global Top Exosomes Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Exosomes Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Exosomes Product Solution and Service
Table 24. Date of Enter into Exosomes Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Exosomes Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Exosomes Revenue Market Share by Type (2018-2023)
Table 28. Global Exosomes Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Exosomes Revenue Market Share by Type (2024-2033)
Table 30. Global Exosomes Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Exosomes Revenue Market Share by Application (2018-2023)
Table 32. Global Exosomes Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global Exosomes Revenue Market Share by Application (2024-2033)
Table 34. North America Exosomes Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. North America Exosomes Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Exosomes Market Size by Country (2024-2033) & (US$ Million)
Table 37. Europe Exosomes Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. Europe Exosomes Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Exosomes Market Size by Country (2024-2033) & (US$ Million)
Table 40. Asia-Pacific Exosomes Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 41. Asia-Pacific Exosomes Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Exosomes Market Size by Region (2024-2033) & (US$ Million)
Table 43. Latin America Exosomes Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Latin America Exosomes Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Exosomes Market Size by Country (2024-2033) & (US$ Million)
Table 46. Middle East & Africa Exosomes Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Middle East & Africa Exosomes Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Exosomes Market Size by Country (2024-2033) & (US$ Million)
Table 49. Fujifilm Company Detail
Table 50. Fujifilm Business Overview
Table 51. Fujifilm Exosomes Product
Table 52. Fujifilm Revenue in Exosomes Business (2018-2023) & (US$ Million)
Table 53. Fujifilm Recent Development
Table 54. Thermo Fisher Scientific Company Detail
Table 55. Thermo Fisher Scientific Business Overview
Table 56. Thermo Fisher Scientific Exosomes Product
Table 57. Thermo Fisher Scientific Revenue in Exosomes Business (2018-2023) & (US$ Million)
Table 58. Thermo Fisher Scientific Recent Development
Table 59. Danaher Company Detail
Table 60. Danaher Business Overview
Table 61. Danaher Exosomes Product
Table 62. Danaher Revenue in Exosomes Business (2018-2023) & (US$ Million)
Table 63. Danaher Recent Development
Table 64. Illumina Company Detail
Table 65. Illumina Business Overview
Table 66. Illumina Exosomes Product
Table 67. Illumina Revenue in Exosomes Business (2018-2023) & (US$ Million)
Table 68. Illumina Recent Development
Table 69. Qiagen Company Detail
Table 70. Qiagen Business Overview
Table 71. Qiagen Exosomes Product
Table 72. Qiagen Revenue in Exosomes Business (2018-2023) & (US$ Million)
Table 73. Qiagen Recent Development
Table 74. Takara Bio Company Detail
Table 75. Takara Bio Business Overview
Table 76. Takara Bio Exosomes Product
Table 77. Takara Bio Revenue in Exosomes Business (2018-2023) & (US$ Million)
Table 78. Takara Bio Recent Development
Table 79. Malvern Instruments Company Detail
Table 80. Malvern Instruments Business Overview
Table 81. Malvern Instruments Exosomes Product
Table 82. Malvern Instruments Revenue in Exosomes Business (2018-2023) & (US$ Million)
Table 83. Malvern Instruments Recent Development
Table 84. Miltenyi Biotec Company Detail
Table 85. Miltenyi Biotec Business Overview
Table 86. Miltenyi Biotec Exosomes Product
Table 87. Miltenyi Biotec Revenue in Exosomes Business (2018-2023) & (US$ Million)
Table 88. Miltenyi Biotec Recent Development
Table 89. MBL International Company Detail
Table 90. MBL International Business Overview
Table 91. MBL International Exosomes Product
Table 92. MBL International Revenue in Exosomes Business (2018-2023) & (US$ Million)
Table 93. MBL International Recent Development
Table 94. Lonza Company Detail
Table 95. Lonza Business Overview
Table 96. Lonza Exosomes Product
Table 97. Lonza Revenue in Exosomes Business (2018-2023) & (US$ Million)
Table 98. Lonza Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Exosomes Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Exosomes Market Share by Type: 2022 VS 2033
Figure 3. Non-coding RNAs Features
Figure 4. Lipids Features
Figure 5. mRNA Features
Figure 6. DNA fragments Features
Figure 7. Proteins /peptides Features
Figure 8. Global Exosomes Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 9. Global Exosomes Market Share by Application: 2022 VS 2033
Figure 10. Cancer Case Studies
Figure 11. Infectious diseases Case Studies
Figure 12. Neurodegenerative diseases Case Studies
Figure 13. Cardiovascular diseases Case Studies
Figure 14. Exosomes Report Years Considered
Figure 15. Global Exosomes Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 16. Global Exosomes Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 17. Global Exosomes Market Share by Region: 2022 VS 2033
Figure 18. Global Exosomes Market Share by Players in 2022
Figure 19. Global Top Exosomes Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exosomes as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Exosomes Revenue in 2022
Figure 21. North America Exosomes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. North America Exosomes Market Share by Country (2018-2033)
Figure 23. United States Exosomes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Canada Exosomes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Exosomes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe Exosomes Market Share by Country (2018-2033)
Figure 27. Germany Exosomes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. France Exosomes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. U.K. Exosomes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Italy Exosomes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Russia Exosomes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Nordic Countries Exosomes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Exosomes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Asia-Pacific Exosomes Market Share by Region (2018-2033)
Figure 35. China Exosomes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Japan Exosomes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. South Korea Exosomes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Southeast Asia Exosomes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. India Exosomes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Australia Exosomes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Exosomes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Latin America Exosomes Market Share by Country (2018-2033)
Figure 43. Mexico Exosomes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Brazil Exosomes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Exosomes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East & Africa Exosomes Market Share by Country (2018-2033)
Figure 47. Turkey Exosomes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Saudi Arabia Exosomes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Fujifilm Revenue Growth Rate in Exosomes Business (2018-2023)
Figure 50. Thermo Fisher Scientific Revenue Growth Rate in Exosomes Business (2018-2023)
Figure 51. Danaher Revenue Growth Rate in Exosomes Business (2018-2023)
Figure 52. Illumina Revenue Growth Rate in Exosomes Business (2018-2023)
Figure 53. Qiagen Revenue Growth Rate in Exosomes Business (2018-2023)
Figure 54. Takara Bio Revenue Growth Rate in Exosomes Business (2018-2023)
Figure 55. Malvern Instruments Revenue Growth Rate in Exosomes Business (2018-2023)
Figure 56. Miltenyi Biotec Revenue Growth Rate in Exosomes Business (2018-2023)
Figure 57. MBL International Revenue Growth Rate in Exosomes Business (2018-2023)
Figure 58. Lonza Revenue Growth Rate in Exosomes Business (2018-2023)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed